Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
SGLT-2 inhibitors are a class of drugs that prevent kidney reabsorption of sugar and thus lower blood sugar levels
Clinical studies also show improved glucose regulation, which is beneficial for patients with diabetes, insulin resistance, or borderline blood sugar levels
Rotating injection sites between the abdomen, thigh, and upper arm, as instructed in the SmPC, minimises this risk
Typically, it is administered once weekly by subcutaneous injection
In the UK, NICE recommends GLP-1 receptor agonists for type 2 diabetes in specific circumstances (NG28), such as when metformin is insufficient and BMI 30 kg/m
US$ 20.40
US$ 21.64
US$ 21.46
US$ 24.38
US$ 29.29
